Waste Nitrogen Excretion Via Amino Acid Acylation: Benzoate and Phenylacetate in Lysinuric Protein Intolerance
- 31 October 1986
- journal article
- research article
- Published by Springer Nature in Pediatric Research
- Vol. 20 (11) , 1117-1121
- https://doi.org/10.1203/00006450-198611000-00011
Abstract
Benzoate and phenylacetate improve prognosis in inherited urea cycle enzyme deficiencies by increasing waste nitrogen excretion as amino acid acylation products. We studied metabolic changes caused by these substances and their pharmacokinetics in a biochemically different urea cycle disorder, lysinuric protein intolerance (LPI), under strictly standardized induction of hyperammonemia. Five patients with LPI received an intravenous infusion of 6.6 mmol/kg L-alanine alone and separately with 2.0 mmol/kg of benzoate or phenylacetate in 90 min. Blood for ammonia, serum urea and creatinine, plasma benzoate, hippurate, phenylacetate, phenylacetylglutamine, and amino acids was obtained at 0, 120, 180, and 270 min. Urine was collected in four consecutive 6-h periods. Alanine caused hyperammonemia: maximum increase 107, 28-411 µM (geometric mean, 95% confidence interval); ammonia increments were nearly identical after alanine + benzoate (60, 17-213 µM) and alanine + phenylacetate (79, 13-467 µM) (NS). Mean plasma benzoate was 6.0 mM when extrapolated to the end of alanine + benzoate infusions; phenylacetate was 4.9 mM at the end of alanine + phenylacetate. Transient toxicity (dizziness, nausea, vomiting) occurred in four patients at the end of combined infusions, and we suggest upper therapeutic plasma concentrations of 4.5 mM for benzoate and 3.5 mM for phenylacetate. Benzoate and phenylacetate then decreased following first-order kinetics with t1/2s of 273 and 254 min, respectively. Maximal plasma hippurate (0.24, 0.14-0.40 mM) was lower than maximal phenylacetylglutamine (0.48, 0.22-1.06 mM, p=0.008). Orotic acid excretion was 5.62, 1.84-17.14 µmol/kg per h after alanine, but only 1.07, 0.04-25.62 µmol/kg per h after alanine + benzoate (pp<0.016). Urea excretions were in the same range after all loads. Urinary hippurate nitrogen after alanine + benzoate and phenylacetylglutamine, nitrogen after alanine + phenylacetate accounted for an average of 12 and 22 of that in urea in the first 6 h. Of the benzoate and phenylacetate given, 65 and 51% were excreted in 24 h as hippurate and phenylacetyl-glutamine, respectively; less than 3.5% appeared unchanged in urine.Keywords
This publication has 10 references indexed in Scilit:
- Arginine, an indispensable amino acid for patients with inborn errors of urea synthesis.Journal of Clinical Investigation, 1984
- Treatment of Episodic Hyperammonemia in Children with Inborn Errors of Urea SynthesisNew England Journal of Medicine, 1984
- "BASOLATERAL" AND MITOCHONDRIAL MEMBRANE TRANSPORT DEFECT IN THE HEPATOCYTES IN LYSINURIC PROTEIN INTOLERANCEActa Paediatrica, 1983
- Treatment of Inborn Errors of Urea SynthesisNew England Journal of Medicine, 1982
- Orotic Aciduria in Lysinuric Protein Intolerance: Dependence on the Urea Cycle IntermediatesPediatric Research, 1981
- Lysinuric protein intolerance: A two-year trial of dietary supplementation therapy with citrulline and lysineThe Journal of Pediatrics, 1980
- Lysine Fluxes across the Jejunal Epithelium in Lysinuric Protein IntoleranceJournal of Clinical Investigation, 1980
- BASOLATERAL-MEMBRANE TRANSPORT DEFECT FOR LYSINE IN LYSINURIC PROTEIN INTOLERANCEThe Lancet, 1980
- Intestinal absorption in lysinuric protein intolerance: impaired for diamino acids, normal for citrulline.Gut, 1980
- The Effect of Ammonia Administration on Orotic Acid Excretion in RatsJournal of Biological Chemistry, 1965